{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:32:30Z","timestamp":1790674350701,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bcmd.2018.07.001","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T12:36:05Z","timestamp":1533904565000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Coexistence of Gaucher Disease and severe congenital neutropenia"],"prefix":"10.1016","volume":"76","author":[{"given":"Melis Demir","family":"Kose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Canda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehtap","family":"Ka\u011fn\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema Kalkan","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Onay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eser","family":"Y\u0131ld\u0131r\u0131m Sozmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Karap\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferda","family":"\u00d6zk\u0131nay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"\u00c7oker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9645","key":"10.1016\/j.bcmd.2018.07.001_bb0005","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet (Lond. Engl.)"},{"issue":"2","key":"10.1016\/j.bcmd.2018.07.001_bb0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"18","key":"10.1016\/j.bcmd.2018.07.001_bb0015","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.bcmd.2018.07.001_bb0020","first-page":"457","article-title":"Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals","volume":"13","author":"Wang","year":"2011","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"10.1016\/j.bcmd.2018.07.001_bb0025","doi-asserted-by":"crossref","first-page":"17032","DOI":"10.1038\/nrdp.2017.32","article-title":"Severe congenital neutropenias","volume":"3","author":"Skokowa","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.bcmd.2018.07.001_bb0030","first-page":"73","article-title":"HAX-1 deficiency: characteristics of five cases including an asymptomatic patient","volume":"34","author":"Aydogmus","year":"2016","journal-title":"Asian Pac. J. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.bcmd.2018.07.001_bb0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ng1940","article-title":"HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)","volume":"39","author":"Klein","year":"2007","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bcmd.2018.07.001_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10875-016-0358-2","article-title":"Kostmann's disease and HCLS1-associated protein X-1 (HAX1)","volume":"37","author":"Klein","year":"2017","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.bcmd.2018.07.001_bb0045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2010.08216.x","article-title":"Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy","volume":"150","author":"Rosenberg","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.bcmd.2018.07.001_bb0050","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/pbc.21282","article-title":"A molecular classification of congenital neutropenia syndromes","volume":"49","author":"Boxer","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"issue":"5","key":"10.1016\/j.bcmd.2018.07.001_bb0055","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood-2006-08-019166","article-title":"Neutrophil elastase in cyclic and severe congenital neutropenia","volume":"109","author":"Horwitz","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bcmd.2018.07.001_bb0060","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.4049\/jimmunol.158.6.2736","article-title":"HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases","volume":"158","author":"Suzuki","year":"1997","journal-title":"J. Immunol. (Baltim. MD: 1950)"},{"issue":"10","key":"10.1016\/j.bcmd.2018.07.001_bb0065","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1182\/blood-2007-11-120667","article-title":"Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations","volume":"111","author":"Germeshausen","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcmd.2018.07.001_bb0070","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2796.2008.01982.x","article-title":"Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations","volume":"264","author":"Carlsson","year":"2008","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.bcmd.2018.07.001_bb0075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jmb.2008.04.020","article-title":"Existence of multiple isoforms of HS1-associated protein X-1 in murine and human tissues","volume":"379","author":"Lees","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcmd.2018.07.001_bb0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/17474086.2016.1112732","article-title":"Hematological manifestations and complications of Gaucher disease","volume":"9","author":"Linari","year":"2016","journal-title":"Expert. Rev. Hematol."},{"issue":"1","key":"10.1016\/j.bcmd.2018.07.001_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajh.2830430118","article-title":"Correction of neutrophil chemotaxis defect in patients with Gaucher disease by low-dose enzyme replacement therapy","volume":"43","author":"Zimran","year":"1993","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.bcmd.2018.07.001_bb0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10245330500067181","article-title":"Survey of hematological aspects of Gaucher disease","volume":"10","author":"Zimran","year":"2005","journal-title":"Hematology (Amst. Neth.)"},{"issue":"2","key":"10.1016\/j.bcmd.2018.07.001_bb0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2141.1993.tb08270.x","article-title":"Abnormal neutrophil chemotaxis in Gaucher disease","volume":"83","author":"Aker","year":"1993","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2018.07.001_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1750-1172-7-77","article-title":"The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients","volume":"7","author":"Stirnemann","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"25","key":"10.1016\/j.bcmd.2018.07.001_bb0105","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1073\/pnas.1200941109","article-title":"Gaucher disease gene GBA functions in immune regulation","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bcmd.2018.07.001_bb0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bcmd.2018.07.001_bb0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bcmd.2014.12.003","article-title":"Impaired migration capacity in monocytes derived from patients with Gaucher disease","volume":"55","author":"Bettman","year":"2015","journal-title":"Blood Cells Mol. Dis."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979618300573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979618300573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:33:33Z","timestamp":1761050013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979618300573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":23,"alternative-id":["S1079979618300573"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2018.07.001","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coexistence of Gaucher Disease and severe congenital neutropenia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2018.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}